The company who manufactures ... the first person in the UK whose death has officially been linked to the rising trend of ...

Susan McGowan, 58, from Lanarkshire, died from multiple organ failure, septic shock and pancreatitis after taking two ...

Even a juggernaut like Eli Lilly ( LLY 2.71%) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor ...

Another issue for investors is that Eli Lilly adjusted its guidance for the year, now projecting its adjusted EPS to fall ...

--Longest losing streak since Aug. 5, 2022, when it fell for six straight trading days --Worst six day stretch since the six days ending March 25, 2020, when it fell 14.85% --Down 19.3% from its ...

Novo’s obesity drug sales nearly doubled outside the U.S. during the quarter as global demand continued to rise.

The Eli Lilly (NYSE:LLY) share price fell by double digits in the S&P 500 today, leaving this Fool debating whether he should ...

Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two ...

Weight-loss drugmaker Eli Lilly delivered lower sales and earnings per share than expected in the third quarter, blaming high ...